Malnutrition and Nutrition in Dialysis Patients/Diyaliz Hastalarında Malnütrisyon ve Beslenme

Yıl 2026, Cilt: 21 Sayı: 1, 48 - 55, 31.01.2026

Aslı Kürkçü , Asiye Akyol

https://doi.org/10.47565/ndthdt.2026.123

https://izlik.org/JA77FD38DC

Öz

Malnutrition is a common and serious complication among dialysis patients, leading to increased morbidity and mortality. Insufficient nutrient intake results in reduced body weight and energy stores, loss of muscle mass, and decreased visceral protein levels. This condition increases the risk of infections, suppresses immune function, and delays wound healing. The main causes of malnutrition include poor appetite, restrictive diets, medication side effects, metabolic acidosis, inflammation, alterations in the gut microbiota, and nutrient losses that occur during dialysis. Compared to healthy individuals, dialysis patients have higher protein requirements, and an intake of 1.2 g/kg/day is recommended. Energy needs vary depending on physical activity level but generally range from 35-40 kcal/kg/day. Assessment of malnutrition involves biochemical parameters, dietary protein intake, anthropometric measurements, and body composition analysis. Serum albumin is the most commonly used marker, and low levels are associated with higher mortality. Malnutrition not only increases mortality risk but also negatively affects quality of life. Nutritional management should focus on individualized dietary plans and psychosocial support to prevent and treat this condition. The aim of this review is to comprehensively evaluate the prevalence, causes, and consequences of malnutrition in dialysis patients based on current literature.

Anahtar Kelimeler

Albumin , Dialysis , Malnutrition , Undernutrition

Diyaliz Hastalarında Malnütrisyon ve Beslenme/Malnutrition and Nutrition in Dialysis Patients

https://izlik.org/JA77FD38DC

Öz

Malnütrisyon, diyaliz hastalarında sık görülen ve yüksek morbidite ile mortaliteye neden olan önemli bir komplikasyondur. Yetersiz besin alımı, vücut ağırlığı ve enerji depolarında azalmaya, kas kütlesinde kayba ve visseral protein seviyelerinde düşüşe yol açar. Bu durum enfeksiyon riskini artırır, bağışıklığı baskılar ve yara iyileşmesini geciktirir. Malnütrisyonun başlıca nedenleri arasında iştahsızlık, kısıtlayıcı diyetler, ilaç yan etkileri, metabolik asidoz, inflamasyon, bağırsak mikrobiyotasındaki değişiklikler ve diyaliz sırasında yaşanan besin kayıpları yer alır. Diyaliz hastalarında protein ihtiyacı sağlıklı bireylere göre daha yüksektir ve günde kilogram başına 1,2 g protein alımı önerilmektedir. Enerji ihtiyacı ise yaş ve fiziksel aktivite düzeyine bağlı olarak günde 30-35 kcal/kg’dır. Malnütrisyonun değerlendirilmesinde biyokimyasal parametreler, diyet protein alımı, antropometrik ölçümler ve vücut kompozisyon analizleri kullanılmaktadır. Serum albümin seviyesi en yaygın kullanılan parametre olup düşük seviyeler yüksek ölüm oranı ile ilişkilidir. Malnütrisyon, mortalite riskini artırırken yaşam kalitesini olumsuz etkiler. Beslenme yönetimi, bireyselleştirilmiş diyet planları ve psikososyal destek ile bu durumun önlenmesi ve tedavisi hedeflenmelidir. Bu derlemenin amacı, diyaliz hastalarında malnütrisyonun görülme sıklığını, nedenlerini ve sonuçlarını mevcut literatür doğrultusunda kapsamlı şekilde değerlendirmektir.

Anahtar Kelimeler

Albümin , Diyaliz , Malnütrisyon , Yetersiz Beslenme

Kaynakça

• 1. Seyahi N, Koçyiğit İ, Eren N, Tonbul HZ, Tatar E, Yılmaz Z, et al. Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2023 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2025;34(2):141-8. doi: 10.5152/turkjnephrol.2025.24978
• 2. National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Chronic Kidney Disease: 2020 Update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1-107. doi:10.1053/j.ajkd.2020.05.006
• 3. Rashid I, Sahu G, Tiwari P, Willis C, Asche CV, Bagga TK, et al. Malnutrition as a potential predictor of mortality in chronic kidney disease patients on dialysis: A systematic review and meta-analysis. Clin Nutr. 2024;43(7):1760-9. doi: 10.1016/j.clnu.2024.05.037.
• 4. Wang L, Zhang X, Li Y, Chen J, Liu Q, Zhao Y, et al. Malnutrition as a predictor of mortality among patients with chronic kidney disease on dialysis: A systematic review and meta-analysis. J Ren Nutr. 2025;35(2):101-12. doi:10.1016/j.jrn.2025.01.005
• 5. Nelson EE, Hong CD, Pesce AL, Peterson DW, Singh S, Pollak VE. Anthropometric norms for the dialysis population. Am J Kidney Dis. 1990;16:32-7. doi: 10.1016/s0272-6386(12)80782-7
• 6. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr. 1980;33(7):1567-85. doi:10.1093/ajcn/33.7.1567
• 7. Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis. 1993;21(2):125-37. doi: 10.1016/s0272-6386(12)81083-3
• 8. Balcı K, Ural MS, Kavaklı M. Serum albumin trajectories and mortality in hemodialysis patients: A joint model analysis. Ren Replace Ther. 2021;10:67. doi:10.1186/s41100-024-00579-3
• 9. Huu DN, Quy QB, Minh NT, Khanh HN, Tuan NM, Van Khoa T, et al. Low serum prealbumin concentration predicts long-term mortalityin maintenance hemodialysis patients. JGH Open. 2021;5(12):1344-50. doi:10.1002/jgh3.12677
• 10. Sahathevan S, Lim WH, Ng HM, Gafor AHA, Tan LH, Bavanandan S, et al. Associations among serum transferrin levels, markers of malnutrition, and mortality in hemodialysis patients. J Am Soc Nephrol. 2024;35(10):4075-85. doi:10.1681/ASN.2024070143
• 11. Chen Z, Yamamoto S, Fukasawa R, Morimoto Y, Kaneko K, Akizawa T, et al. Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients. Kidney Int Rep. 2023;8(8):1920-30. doi:10.1016/j.ekir.2023.05.018
• 12. Zheng CM, Ho Y, Chen Y, Lin MY, Wang SY, Chang KY, et al. The modulating effect of dietary protein intake on mortality in long-term hemodialysis patients: A nationwide population-based study. BMC Nephrol. 2021;22:345. doi:10.1186/s12882-021-02576-9
• 13. Seto Y, Kimura M, Matsunaga T, Tanaka T, Okazaki S, Onoue T, et al. Long-term body composition changes in patients undergoing hemodialysis: A single-center retrospective study. Ren Replace Ther. 2022;8(1):57. doi:10.1186/s41100-022-00448-x
• 14. Yajima T, Hayase T, Takakuwa T, Yajima K, Takahashi H, Yasuda K. Association of extracellular water/total body water ratio with protein-energy wasting and mortality in hemodialysis patients: A prospective cohort study. Sci Rep. 2023;13:14639.doi:10.1038/s41598-023-41131-3
• 15. Bolasco P, Cupisti A, Locatelli F, Caria S, Kalantar-Zadeh K. Dietary management of incremental transition to dialysis therapy: Once-weekly hemodialysis combined with low-protein diet. J Ren Nutr. 2016;26:352-9. doi: 10.1053/j.jrn.2016.01.015
• 16. Lin Z, Qin X, Yang Y, Zhang W, Wang J, Hu J, et al. The association between dietary energy intake and the risk of mortality in maintenance haemodialysis patients: a multi-centre prospective cohort study. Br J Nutr. 2021;126(10):1510-8. doi:10.1017/S0007114521000210
• 17. Qin A, Tan J, Hu W, Li J, Liu X, Mo L, et al. Oral energy supplementation improves nutritional status in hemodialysis patients with protein–energy wasting: A pilot study. Front Pharmacol. 2022;13:839803. doi:10.3389/fphar.2022.839803
• 18. Hendriks JH, van der Sande FM, Kooman JP. Amino acid loss during hemodialysis and the effect of intradialytic nutrition. J Ren Nutr. 2020;30(1):12-20. doi:10.1053/j.jrn.2019.10.002
• 19. Wang X, Zhao R, Liu H. Amino acid loss and protein-energy wasting in hemodialysis patients: A narrative review. Int Urol Nephrol. 2024;56(5):987-99. doi:10.1007/s11255-024-03965-4
• 20. Sabatino A, Regolisti G, Karupaiah T, Stenvinkel P, Kaysen GA. Daily amino acid loss in hemodialysis and its contribution to protein-energy wasting. Nutrients. 2022;14(14):2810. doi:10.3390/nu14142810
• 21. Zhang L, Chen X, Li Y. Impact of dialysis modalities on small-molecule and amino acid clearance in hemodialysis patients. Hemodial Int. 2024;28(3):233-45. doi:10.1111/hdi.13120
• 22. Miyamoto Y, Shirouzu T. Dialysis prescription to minimize amino acid loss. J Am Soc Nephrol. 2025;36(10):727-39.doi:10.1681/ASN.2025tgkj0ek2
• 23. Upadhyay A, Jaber BL. Reuse and biocompatibility of hemodialysis membranes: Clinically relevant? Semin Dial. 2017;30(2):121-4. doi:10.1111/sdi.12574
• 24. Ribeiro IC, Roza NAV, Duarte DA, Guadagnini D, Elias RM, Oliveira RB. Clinical and microbiological effects of dialyzers reuse in hemodialysis patients. J Bras Nefrol. 2019;41(3):384-92. doi:10.1590/2175-8239-JBN-2018-0151
• 25. Özkan İ, Taylan S, Kurt Y. Relationship between altered taste and smell with malnutrition among hemodialysis patients. Hemodial Int. 2024;28(3):358-66. doi:10.1111/hdi.1315
• 26. Ferrara G, Rossi M, Lombardi A. Anosmia, dysgeusia and malnutrition in chronic kidney disease: a systematic review. Nefrol (Engl Ed). 2025;45(2):106-15. doi:10.1016/j.nefroe.2025.02.002
• 27. Lasisi TO, Raji Y, Yusuf T, Salako BL. Effect of chronic kidney disease on olfactory function: a case–control study. Ear Nose Throat J. 2023;102(3):188-92. doi:10.1177/0145561321996628
• 28. Notomi S, Kitamura M, Yamaguchi K, Komine M, Sawase K, Nishino T, et al. Anorexia assessed by simplified nutritional appetite questionnaire and association with medication in older patients undergoing hemodialysis. Biol Pharm Bull 2023;46(2):286-91.doi:10.1248/bpb.b22 00719
• 29. Hamdan Z, Nazzal Z, Al Amouri FM, Ishtayah S, Sammoudi S, Bsharat L, et al. Factors associated with malnutrition inflammation score among hemodialysis patients: a cross-sectional investigation in a tertiary care hospital, Palestine. PLoS One. 2025;20(1):e0317132. doi:10.1371/journal.pone.0317132
• 30. Graterol Torres F, Molina M, Soler-Majoral J, Romero-González G, Rodriguez-Espinosa D, de Los Reyes B, et al. Evolving concepts oninflammatory biomarkers and malnutrition in chronic kidney disease. Nutrients. 2022;14(20):4297. doi:10.3390/nu14204297
• 31. Deger SM, Hewlett JR, Gamboa J, Edwards TL, Ellis CD, Siew ED, et al. Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease. Am J Physiol Endocrinol Metab. 2018;315(6):E1108-20. doi:10.1152/ajpendo.00070.2018
• 32. Wang K, Liu Q, Tang M, Liang X, Dong Z. Chronic kidney disease–induced muscle atrophy: Molecular mechanisms and promising therapies. Biochem Pharmacol. 2023;208:115407. doi:10.1016/j.bcp.2022.115407
• 33. Chang J, Liang Y, Sun P, Fang X, Sun Q. Molecular and cellular mechanisms linking chronic kidney disease and sarcopenia in aging: an integrated perspective. Clin Interv Aging. 2025;20:449-58. doi:10.2147/CIA.S516704
• 34. Chen X, Han P, Song P, Wang H, Wang S, Zhao S, et al. Mediating effects of malnutrition on the relationship between depressive symptom clusters and muscle function rather than muscle mass in older hemodialysis patients. J Nutr Health Aging. 2022;26(5):461-8.doi:10.1007/s12603-021-1678-0
• 35. Morvaridi M, Behbahani HB, Alipour M, Mousavi SM, Zarezadeh M, Mohammadi H. The association of malnutrition-inflammation score with sleep quality and mental health in hemodialysis patients: A multicenter cross-sectional study. BMC Nephrol. 2025;26:305. doi:10.1186/s12882-025-04089-0
• 36. Micozkadioglu H, Micozkadioglu I, Zumrutdal A, Erdem A, Ozdemir FN, Sezer S, et al. Relationship between depressive affect and malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrology (Carlton). 2006;11(6):502-5.doi: 10.1111/j.1440-1797.2006.00664.x.
• 37. Carrero JJ, Severs D, Aguilera D, Amptoulach S, Bermudez-Lopez M, Cano N, et al. Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom? Clin Kidney J. 2023;16(1):5-18. doi:10.1093/ckj/sfac171
• 38. Martin-Alemañy G, Perez-Navarro M, Wilund KR, García-Villalobos G, Gómez-Guerrero I, Cantú-Quintanilla G, et al. Effect of intradialytic oral nutritional supplementation with or without exercise on muscle mass, quality and physical function. Nutrients. 2022;14(14):2946. doi:10.3390/nu14142946